1. Pink Sheet
  2. >>Geography
  3. >>Europe

ABPI’s 6.88% Rebate Proposal ‘Completely Unaffordable,’ Says UK Health Dept

 
• By Francesca Bruce

Plans for a new kind of drug pricing scheme put forward by the UK ABPI are intended to put the life sciences sector “back on the path for future growth,” the association says.

Pound Blister Pack
• Source: Shutterstock

The Association of the British Pharmaceutical Industry has put forward proposals for a “Voluntary Scheme for Pricing, Access and Growth” (VPAG), with a sales rebate of just 6.88%, to replace the current voluntary scheme, which expires at the end of 2023 and has a rebate rate of 26.5% for this year.

The proposals aim to help ensure the life sciences industry contributes to UK economic growth, that the provision of medicines is sustainable, that access to and uptake of new medicines is rapid and that health

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

EU Shaping Biotech Act To Unleash SME Potential

 
• By Neena Brizmohun

European companies, in particular small and midsize enterprises, spin-offs and start-ups have a hard time expanding within the single market “because of a complex regulatory framework that is perceived as slow and burdensome,” according to the European Commission.

New EU Filings

 
• By Neena Brizmohun

Brensocatib, Insmed's investigational treatment for non-cystic fibrosis bronchiectasis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.